Estrogen receptor modulators

Details for Australian Patent Application No. 2005254949 (hide)

Owner Merck & Co., Inc.

Inventors Gude, Candido; Blizzard, Timothy A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005254949

PCT Pub. Number WO2005/123757

Priority 60/578,525 10.06.04 US

Filing date 7 June 2005

Wipo publication date 29 December 2005

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123757 Priority application(s): WO2005/123757

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254950-Glucagon receptor antagonists, preparation and therapeutic uses

2005254945-2,4-Diaminoquinazolines for spinal muscular atrophy